Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
|
• |
|
Forms S-3 (File No. 333-283307, 333-284222, and 333-288213) of Inhibikase Therapeutics, Inc., and |
|
• |
|
Forms S-8 (File No. 333-259555 and 333-284687) pertaining to the Inhibikase Therapeutics, Inc. 2020 Equity Incentive Plan. |
|
|
|
|
|
• |
|
Form S-8 (File No. 333-286182) pertaining to the Stock Option Inducement Awards of Inhibikase Therapeutics, Inc. |
of our report dated March 26, 2026, with respect to the consolidated financial statements of Inhibikase Therapeutics, Inc. and Subsidiaries included in this Annual Report (Form 10-K) of Inhibikase Therapeutics, Inc. and Subsidiaries for the year ended December 31, 2025.
|
/s/ CohnReznick LLP |
Holmdel, New Jersey |
March 26, 2026 |